Itron’s fourth quarter results drew a strong positive reaction from the market, as management emphasized robust execution amid a shifting utility landscape. CEO Thomas Deitrich attributed performance ...
PACS Group leaders reported a landmark 2025 during the company’s fourth-quarter earnings call Thursday, highlighting a year defined by record financial outcomes.
Telix Pharmaceuticals focuses on radiopharmaceuticals for the diagnosis and treatment of cancer.
Synopsys stock analysis: wide moat, AI-driven chip complexity growth, and Ansys deal impact. Read more macro analysis here.
JINAN, SHANDONG, CHINA, February 14, 2026 /EINPresswire.com/ -- As the global energy landscape approaches the midpoint ...
Q4 2025 earnings call recap: record $44B backlog, strong cash flow, and 2026 outlook for 20%+ EPS growth—read now.
Herc Holdings’ fourth quarter was marked by significant operational change following the completion of its largest-ever industry acquisition. The market responded negatively to earnings, reflecting ...
Free cash flow conversion is projected at 80% for 2026, a decrease from 2025 levels as the company becomes a full cash taxpayer after exhausting net operating losses (NOLs). Strategic initiatives ...
JBT Marel Corporation (NYSE: JBT) Q4 2025 Earnings Call Transcript February 24, 2026 ...
Verisk Analytics, Inc. (NASDAQ:VRSK) Q4 2025 Earnings Call Transcript February 18, 2026 Verisk Analytics, Inc. misses on earnings expectations. Reported EPS is $1.42 EPS, expectations were $1.6.